Rice University, MD Anderson initiative aims to improve cancer research, diagnosis and treatment

by · PR Newswire

Cancer Bioengineering Collaborative hosts kickoff event, awards first round of seed grants

HOUSTON, Oct. 31, 2024 /PRNewswire/ -- Leaders and researchers from Rice University and the University of Texas MD Anderson Cancer Center came together this month to celebrate the launch of the Cancer Bioengineering Collaborative, first announced earlier this summer.

The Cancer Bioengineering Collaborative is a joint initiative between the two institutions created to develop innovative technologies and bioengineering approaches to improve cancer research, diagnosis and treatment.

(From left) James Allison, regental professor and chair of immunology and director of the James P. Allison Institute at MD Anderson; Jeffrey Molldrem, chair of hematopoietic biology and malignancy at MD Anderson; Reginald DesRoches, Rice University president; Eyal Gottlieb, MD Anderson’s vice president for research; and Gang Bao, department chair and Foyt Family Professor of Bioengineering, professor of chemistry, materials science and nanoengineering at Rice.